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Available online 9 November 2016Background:Mobile phone use has been increasing rapidly in the past decades and, in parallel, so has the annual
incidence of certain types of brain cancers. However, it remainsunclearwhether this correlation is coincidental or
whether use of mobile phones may cause the development, promotion or progression of speciﬁc cancers. The
1985–2014 incidence of selected brain cancer subtypes in England were analyzed and compared to counterfac-
tual ‘synthetic control’ timeseries.
Methods: Annual 1985–2014 incidence ofmalignant glioma, glioblastomamultiforme, andmalignant neoplasms
of the temporal and parietal lobes in Englandweremodelled based on population-level covariates using Bayesian
structural time series models assuming 5,10 and 15 year minimal latency periods. Post-latency counterfactual
‘synthetic England’ timeseries were nowcast based on covariate trends. The impact of mobile phone use was in-
ferred from differences between measured and modelled time series.
Results: There is no evidence of an increase in malignant glioma, glioblastoma multiforme, or malignant neo-
plasms of the parietal lobe not predicted in the ‘synthetic England’ time series. Malignant neoplasms of the tem-
poral lobe however, have increased faster than expected. A latency period of 10 years reﬂected the earliest
latency period when this was measurable and related to mobile phone penetration rates, and indicated an addi-
tional increase of 35% (95% Credible Interval 9%:59%) during 2005–2014; corresponding to an additional 188
(95%CI 48–324) cases annually.
Conclusions: A causal factor, of whichmobile phone use (and possibly other wireless equipment) is in agreement
with the hypothesized temporal association, is related to an increased risk of developingmalignant neoplasms in
the temporal lobe.
© 2016 The Author. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Mobile phone use has been increasing in Western, developed socie-
ties (de Vocht et al., 2011; Khurana et al., 2009) as well as worldwide
(Khurana et al., 2009), and in parallel the incidence of certain types of
brain cancers has also been increasing in the previous decades (Dobes
et al., 2011; Zada et al., 2012). Although it is not entirely clear what
the cause of the latter is, the temporal correlation between brain cancer
incidence rates and mobile phone use has not gone unnoticed. Mobile
phones utilize (in England) radiofrequency (RF) radiation in the 900–
1800 MHz (2G), 900–2100 MHz (3G) and more recently 800–1800/
2600 MHz (4G) frequency bands, and consequently also expose people
using their phones to RF (Cardis et al., 2011). It remains unclearwhether
the RF exposure from mobile phones could be genotoxic to humans
(Banerjee et al., 2016; Liu et al., 2015). The World Health Organisation
(WHO) International Agency for Research on Cancer (IARC) in 2011. This is an open access article underdeclared, based on the scientiﬁc evidence available at the time, exposure
of humans to RF (frequency range 30 kHz–300 GHz) as “possibly carci-
nogenic to humans” (Group 2B) (Baan and others, 2011). However, con-
ﬂicting interpretations of the available evidence remain (Morgan et al.,
2015; Peres, 2010; Repacholi et al., 2012), while susceptibility of sub-
groups such as children is being investigated (Sadetzki et al., 2014),
and results from the large prospective cohort study COSMOS (Schuz et
al., 2011) are not yet available.
Monitoring of brain tumour incidence trends has been identiﬁed as a
high priority research area and can provide evidence of whether an “ep-
idemic” in brain cancers as a result of the widespread use of mobile
phones may be imminent (Samet et al., 2014; van Deventer et al.,
2011). Moreover, these are important to estimate the magnitude of
the impact of RF exposure from mobile phones on population health
so that appropriate measures could be taken, if required.
Previous work in England did not provide any evidence of a notice-
able change in brain cancer incidence rates in England between 1998
and 2007, nor for speciﬁc brain regions (de Vocht et al., 2011). These
ﬁndings corroborated analyses from other countries (Chapman et al.,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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al., 2015). Similarly, although the incidence of tumours of the parotid
gland and other tumours of the salivary gland have been increasing in
England, these trends were not indicative of mobile phones being a
causative factor (de Vocht, 2011). However, these studies have been
criticized for their short follow-up which, in combination with an aver-
age latency period between exposure and clinical detection of the tu-
mour of at least a decade, would prevent the detection of measureable
changes (Kundi, 2011; Rothman, 2009). Nonetheless, a recent study in
Australia covering 29 years again did not ﬁnd evidence of increased
brain cancer risk related to mobile phone use (Chapman et al., 2016),
but this study did not look at speciﬁc brain cancer subtypes or locations,
while other limitations were also highlighted (Bandara, 2016).
This study aims to analyse time series of speciﬁc brain cancer sub-
types and locations covering the time period of 1985–2014 in England.
More speciﬁcally, two speciﬁc hypotheses are addressed: (1) trends in
histologically-deﬁned brain cancers that have previously been linked
to mobile phone exposure; malignant glioma (Corle et al., 2012) and
glioblastoma multiforme (Grade IV astrocytoma) (Hardell et al., 2013),
or GBM4, and (2) malignant neoplasms of the temporal and parietal
lobes, which receive the highest exposures (Cardis et al., 2008;
Ghanmi et al., 2014), and for which especially the temporal lobe has
been highlighted as an important location of interest (Samet et al.,
2014). Using Bayesian structural time series and a novel causal impact
framework, these analyses further aim to infer the impact of mobile
phone use on population health, if any, by not only evaluating the annu-
al incidence trends of each outcome, but additionally compare it to the
expected, counterfactual, time series (Pearl, 2009).2. Methods
2.1. Data
National annual number of newly registered cases of the selected
cancers for the years 1985–2014 were obtained from the Ofﬁce of Na-
tional Statistics (ONS). Pre-1995 incident caseswere aggregated forma-
lignant glioma (ICD-9 191.9; morphology codes M9380/3, M9400/3,
M9382/3), malignant neoplasms of the temporal lobe (ICD-9 191.2),
malignant neoplasms of the parietal lobe (191.3), and glioblastoma
multiforme (GBM4) (ICD-9 191.9, morphology codes M9440/3,
M9442/3, M9441/3), and from 1995 onwards cancers were aggregated
as malignant glioma (ICD-10 C71.9; morphology codes M9380/3,
M9400/3, M9382/3), malignant neoplasms of the temporal lobe (ICD-
10 C71.2), malignant neoplasms of the parietal lobe (ICD-10 C71.3),
and GBM4 (ICD-10 C71.9, morphology codes M8440/3, M9442/3,
M9441/3). Although age-standardized incidence rates are available,
here the actual numbers of newly diagnosed cases are used to
enable a straightforward quantitative estimation of the population
impact.
The number of cellular mobile phone subscriptions was obtained
from the United Nations specialized agency for information and com-
munication technologies (ITU) (de Vocht et al., 2011; ITU, 2016).
Data on covariates for the years 1985–2014were obtained fromONS
(ONS, 2016b), the Health Survey for England (HSCIC, 2015) and the
Worldbank (Worldbank, 2016) and include incidence of all cancers (ex-
cluding non-melanoma skin cancer), annual population estimates, me-
dian age of the UK population, population prevalence of cigarette
smokers and never smokers, urbanization rate, and a quality measure
for coding of cancer cases coded as the percentage of status 3 records
(record failed one or several vital validation checks on ﬁelds which are
vital for inclusion in ONS tables). Covariate data were interpolated
where they were not available for speciﬁc years. In addition, because
of the transfer from ICD9 to ICD10 in 1995 a dichotomous variable for
the years 1993–1997 to deal with some short-term disruption of the
time series in that period was included.2.2. Statistical methodology
To infer the impact of mobile phone use on the annual incidence of
the selected brain cancers, Bayesian structural time series models are
utilized (Scott and Varian, 2014). In short, the time series from 1985
up to an a priori speciﬁed point in time is modelled using other time se-
ries of covariates that may be correlated with the annual number of
newly registered cases.
The speciﬁed time point referred to above generally refers to some
intervention (Brodersen et al., 2015) or some event expected to change
the time series (such as, for example, an armed conﬂict for which this
methodology has been previously used (Abadie and Gardeazabal,
2003)), but here this is interpreted as the point in time at which, if mo-
bile phone use were associated with increased brain cancer risk, this
would be measurable in population-level data. This design can be
thought of as a natural experiment, and therefore (as well as for ease
of reference) this speciﬁed time point will be referred to as the ‘cut-
off’. In these analyses, three speciﬁc cut-offs were modelled relative to
the year 1995, when mobile phone penetration in England reached
about 10% (ITU, 2016); (1) the year 2000, which implies that increased
risk would be observable ﬁve years later, and thus corresponding to a
detectable latency period between exposure and clinically detectable
tumours of ﬁve years, and subsequently (2) the year 2005 and (3)
2010, corresponding to ten and 15 year minimal latency periods, re-
spectively. The 5–15 year minimal latency time at which an increased
risk would be measurable would correspond to a peak latency period
of up to several decades (Ahlbom and others, 2009). Based on previous
research (Ahlbom and others, 2009; Cardis et al., 2011; Corle et al.,
2012; Hardell et al., 2007; Khurana et al., 2009; Levis et al., 2011), a
priori the hypothesis was that measurable effects, if any, would be ob-
served for the implied 10-year latency. The 0 and 5 year latency periods
were included as control analyses, but additionally would be informa-
tive in relation to the cut-off at 1995, which was about a decade after
the introduction of mobile phones but, somewhat arbitrary, was
thought to signify a point from effects could be measurable at popula-
tion level because cell phone penetration had reached 10%.
Under the assumption that the relationship between the time series
of the annual number of new cases and the time series of covariates (de-
scribed above) that existed prior to the speciﬁed year remains constant
in the period thereafter, the counterfactual ‘post-cut-off’ trend for the
selected cancers is estimated from the time trends in the measured co-
variates by constructing a ‘synthetic England’ (Abadie et al., 2010;
Abadie and Gardeazabal, 2003), which describes what would have hap-
pened had the intervention not happened (i.e. had mobile phones not
been introduced). And ﬁnally, the (causal) impact of mobile phone
use can then be estimated by comparing the time series in the counter-
factual ‘synthetic England’ with the measured annual number of regis-
tered new cases in the period from the ‘cut-off’ to the year 2014.
The Bayesian structural time series model consists of a time series
component that models the temporal trend in the data and a regression
component that captures the impact of the ‘intervention’. The time se-
ries component in turn consists of two equations, with an observation
equation that links the observed data with an unobserved latent state
and a transition equation that deﬁnes how the latent state evolves
over time. The regression component is based on a set of external covar-
iates that contribute to the prediction, and a Bayesian ‘spike and slab
prior’, based on a Bernoulli prior, is used to estimate the effect size of
each covariate in eachMCMC iteration. The “spike” places positive prob-
abilitymass at zero (i.e. a null effect) and the “slab” is a weakly informa-
tive Gaussian prior that describes a non-null effect. Prior standard
deviations are modelled as inverse Gamma distributions. The post-
cut-off time series is then estimated based on the weighted (through
Bayesian model averaging of the predictors) pre-cut-off model coefﬁ-
cients to create the counterfactual ‘synthetic England’ (George and
R.E., 1997; Scott and Varian, 2014). The framework outlined above is de-
scribed in detail elsewhere (Brodersen et al., 2015; Scott and Varian,
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bsts package in R (Scott, 2016), and subsequently used as input for the
CausalImpact R package (Brodersen 2014–2016) to estimate the popula-
tion (causal) impact.
Prior standard deviationwas set at 20% of the sample standard devi-
ation to allow themodelled time series to have enough “freedom”while
at the same time retaining predictive power. Gaussian priors were set
with mean to the incidence in the year 1985 and standard deviation
to the pre-period standard deviation. Upper limits for the Gaussian
and Inverse Gamma standard deviation priors were set to 150% of the
observed standard deviation. Priors for the effects sizes were set to ‘0’
(no effect) with the exception of the intercept whichwas set to the em-
pirical intercept. Prior expected explained variancewas set at 77% based
on initial static regression with prior degrees of freedom set to pre-pe-
riod years. Exploratory analyses indicated additional seasonal or ﬁrst
order autoregressive covariance components did not improve ﬁt.
Convergence of the MCMC chains was assessed through inspection
of the trace plots, Heidelberger-Welch tests, and Geweke diagnostic
tests. Autocorrelation was evaluated using ACF/PACF autocorrelation
plots and Durbin-Watson tests. Precision was estimated frommean ab-
solute 1-step prediction errors and range.
Additional sensitivity analyses were conductedwith stricter and less
informative priors for the standard deviation, and were set to 10% and
50% of the sample standard deviation, respectively. Because the post-
cut-off prediction period was shorter for longer pre-cut-off modelling
periods, sensitivity analyses were conducted with post-cut off periods
to be predicted restricted to 5 years for all analyses. And ﬁnally, to ex-
plore the likelihood mobile phone use may be the causal factors, the
number of mobile phone subscriptionswas included for latency periods
up to 5 years from1995 (or 15 years from1985, respectively) by shifting
the mobile phone subscription trend.3. Results
Numbers of newly registered cases of gliomas and glioblastoma
multiforme, as well as those of malignant tumours of the temporal
and parietal lobes are shown in Fig. 1, and indicate that the annual num-
ber of new glioma cases in England has been decreasing since 1985,
with the notable exception of the 1992–1997 period, while that for
GBM4 increased annually until about 2005, after which it stabilized. In
contrast, the annual number of newly registered cases of malignant
neoplasms of the temporal and parietal lobes have been consistently in-
creasing from 1985.Fig. 1. 1985–2014 annual number of newly registered cases of glioblastoma multiformThe temporal trends of the covariates (standardized for conve-
nience) are shown in Fig. S1 in Online Supplementary Material (OSM)
and show increased trends in all covariates but for the proportion of
smokers in the population and the percentage of status 3 records. Inclu-
sion probabilities of the covariates differs between the differentmodels,
and are shown in OSM (Table S1).
All diagnostics indicate acceptable convergence of MCMC chains
after a maximum of 250,000 MCMC samples (OSM; Table S2). The pre-
diction of the Bayesian structural time series models were relatively ac-
curate with mean (absolute) 1-step prediction errors b10% in all but
one of the models.
Table 1 shows the results of the Bayesianmodelling for selected can-
cers for the different latency periods since 1995 (0,5, 10, and 15 years,
respectively), and are shown graphically for the histological-based can-
cers in Fig. 2 and for the location-based cancers in Fig. 3. There is no ev-
idence of an increase in the incidence ofmalignant glioma or GBM4 that
was not predicted in the counterfactual ‘synthetic England’ time series,
regardless of the latency period. Moreover, although the 95% credible
intervals all include 0%, the point estimates for the effect sizes are al-
most exclusively negative; indicating that based on the counterfactual
‘synthetic England’ higher annual incidences were expected.
Similarly, although continuingly increasing since 1985, the annual
incidence of malignant neoplasms of the parietal lobe is comparable to
the expected trend observed in the counterfactual time series. There is
some evidence that the increase in incidence that has been apparent
since 1985 has been unexpectedly ﬂattening off since about the year
2000 compared to the counterfactual time series, with the incidence
being about 36% (95%CI−70%:−4%) lower than expected.
The annual incidence of malignant neoplasms of the temporal lobe
however, has been increasing faster than expected, with a period of
10 years post-1995 reﬂecting the earliest latency periodwhen this addi-
tional increasewasmeasurable. Post-2005 an additional increase of 35%
(95%CI 9%:59%)was evident compared to the counterfactual time series
in the ‘synthetic England’; corresponding to an average of an additional
188 (95%CI 48–324) cases of malignant neoplasms of the temporal lobe
annually. Addition ofmobile phone penetration in themodels showed a
reduction of 15% in the effect size for 5-year latency (Table 2), indicating
observed increased incidence can, at least in part, by attributed to mo-
bile phone use (Note that unfortunately longer latencies cannot be ex-
plored in these time series).
Sensitivity analyses using different priors show comparable results
to those presented above (OSM Tables S3 and S4). The additional anal-
yses with restricted 5-year ‘nowcasting’ periods conﬁrmed themain re-
sults and indicated excess incidence of malignant neoplasms of thee, malignant glioma, and malignant neoplasms of the parietal and temporal lobes.
Table 1
Inferred impact of mobile phone use (and possibly other wireless technology) on annual incidence of selected brain cancer subtypes.
Implied lag
(from 1995)
Absolute average effect
(95%CI)
Absolute cumulative effect
(95%CI)
Relative effect
(95%CI)
Posterior probability
of effect
Histology based
Malignant gliomaa 0 years −449 (−1116, 355) −8539 (−21,207,6749) −58% (−145%,46%) 0.11
5 years −29 (−308, 330) −403 (−4311, 4618) −9.4 (−100%,108%) 0.37
10 years −63 (−221, 95) −570 (−1993,854) −20% (−71%, 30%) 0.21
15 years −15 (−147, 117) −59 (−589, 469) −6.2% (−62%, 50%) 0.41
Glioblastoma multiformeb 0 years 35 (−385, 547) 657 (−7307, 10,397) 9.1% (−101%, 144%) 0.42
5 years −69 (−549, 311) −967 (−7691, 4361) −14% (−108%, 61%) 0.39
10 years −120 (−364, 117) −1080 (−3279, 1055) −21% (−65%,21%) 0.16
15 years 4.3 (−182, 191) 17.4 (−727, 765) 1% (−43%, 45%) 0.48
Location based
Malignant neoplasms of the temporal lobec 0 years 176 (−36, 446) 3352 (−677, 8471) 43% (−8.8%, 110%) 0.06
5 years 30 (−194, 258) 415 (−2711, 3605) 4.8% (−31%, 42%) 0.42
10 years 188 (48, 324) 1696 (436, 2918) 35% (8.9%, 59%) 0.01
15 years 43 (−127, 213) 170 (−509, 851) 5.5% (−17%, 28%) 0.31
Malignant neoplasms of the parietal lobed 0 years −58 (−312, 226) −1094 (−5926, 4302) −10% (−54%, 39%) 0.31
5 years −290 (−565,−30) −4066 (−7913, 423) −36% (−70%,−3.7%) 0.01
10 years −37 (−148, 71) −332 (−1332, 635) −6.7% (−27%, 13%) 0.25
15 years −44 (−131,40) −175 (−526, 161) −7.9% (−24%, 7.2%) 0.16
a ICD-9 191.9 (morphology codes M9380/3, M9400/3, M9382/3), ICD-10 C71.9 (morphology codes M9380/3, M9400/3, M9382/3).
b ICD-9 191.9 (morphology codes M9440/3, M9442/3, M9441/3), ICD-10 C71.9 (morphology codes M8440/3, M9442/3, M9441/3).
c ICD-9 191.2, ICD-10 C71.2.
d ICD-9 191.3, ICD-10 C71.3.
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only (although the number of new cases of malignant neoplasms of the
parietal lobe was lower than expected from 2000 onwards was ob-
served here as well, similar to the full analyses in Table 1) (OSM Table
S5).
4. Discussion
This research aimed to assess whether the increased incidences of
selected brain cancers observed since 1985 that have been previously
reported as possibly associated with mobile phone use were indeedFig. 2.Measured (solid) andmodelled (dashed) incidence trends (top) and pointwise difference
Credible Intervals.indicative of excess risks compared to their counterfactual time series.
Comparison of the measured and modelled pre-cut-off data indicated
that the measured time series were accurately modelled with absolute
1-step prediction of b10% (b5% in 50% of models) and, under the as-
sumption that the correlations between the different covariates does
not change post-latency period, implies that the counterfactual time se-
ries will have been of similar accuracy.
As such, although the number of newly registered cases of these se-
lected brain tumours has generally been increasing since 1985 (with
the exception ofmalignant glioma), formalignant glioma, GBM4 andma-
lignant neoplasms of the parietal lobe these trends were consistent with(bottom) for histology-based tumours; implied 10-year lag. Grey areas correspond to 95%
Fig. 3.Measured (solid) andmodelled (dashed) incidence trends (top) and pointwise difference (bottom) for location-based brain tumours; implied 10-year lag. Grey areas correspond to
95% Credible Intervals.
104 F. de Vocht / Environment International 97 (2016) 100–107what would be expected if there was no causal association between inci-
dence and mobile phone use. It is likely that the generally observed neg-
ative effects are the results of under-reporting of more recent cases, since
cancer registration in England can take up to ﬁve years after the end of a
given year to reach 100% completeness (ONS, 2016a).With respect to gli-
omas, these ﬁndings are consistent with other incidence studies (Deltour
et al., 2009; Little et al., 2012), themajority of results from cohort (Benson
and others, 2013; Frei et al., 2011) and case-control studies (Corle et al.,
2012), including Interphone (Interphone Study Group, 2010), but not
with all (especially after at least a decade of use) (Coureau et al., 2014;
Hardell and Carlberg, 2015; Hardell et al., 2013; Khurana et al., 2009). In-
creasing trends of GBM4 in the population have also been reported else-
where (Dobes et al., 2011; Zada et al., 2012), but similarly there is little
evidence of deviation from the counterfactual time series (at least in En-
gland). Similarly, the annual number of newly registered cases of malig-
nant neoplasm of the parietal lobe has been increasing since 1985,
which corresponds to the stable population rates also observed else-
where (Zada et al., 2012), and which are comparable to their counterfac-
tual time series. This does not point to mobile phone use as an important
causative factor, which corroborates previous ﬁndings (de Vocht et al.,
2011; Inskip et al., 2010).
In contrast, these analyses do indicate that the observed increase in
incidence of malignant neoplasms in the temporal lobe, which has been
reported previously (de Vocht et al., 2011; Zada et al., 2012), was inTable 2
Inclusion of mobile phone penetration rates with selected latencies for malignant neoplasms o
Implied lag (from 1995) for penetration rate Absolute average effect
(95%CI)
Not included 188
(48, 324)
0 years 1913
(58, 325)
5 years 121
(−597, 799)
10 years No information on effect in pre-inexcess to its expected counterfactual trend. The optimal implied latency
period towhen thiswasmeasurable in population datawas 10 years (or
about 20 years since the introduction of mobile phones in society). Al-
though these analyses are not able to speciﬁcally and unambiguously
link this excess incidence to mobile phone use, this ﬁnding is consistent
with the a priori hypothesis if such a causal association would exist;
both in terms of received exposure compared to other areas of the
brain (Cardis et al., 2008; Ghanmi et al., 2014) and of expected latency
period (Corle et al., 2012; Khurana et al., 2009; Myung et al., 2009).
Moreover, inclusion of mobile phone subscriptions as a putative factor
already (despite the data limitation that does not enable optimal assess-
ment with 10 year latency) nearly halves the effect size, which is simi-
larly consistent with what would be expected in the case of a causal
association. This ﬁnding is in agreement with the Interphone results,
which also indicate a slightly increased risk for gliomas in the temporal
lobe, although this did not reach statistical signiﬁcance (Interphone
Study Group, 2010), and with ﬁndings from Hardell and Carlberg
(Hardell and Carlberg, 2015). The increased incidence inmalignant neo-
plasms in the temporal lobe, in excess of what was expected, was not
previously observed in England (de Vocht et al., 2011) or elsewhere
(Deltour et al., 2009; Inskip et al., 2010; Kim et al., 2015), which may
have been the result of insufﬁcient latency time to observe an effect in
the earlier studies (Kundi, 2011) and/or as a result of the more sophis-
ticated statistical methodology used here.f the temporal lobe.
Absolute cumulative effect
(95%CI)
Relative effect
(95%CI)
Posterior probability
of effect
1696
(436, 2918)
35%
(8.9%, 59%)
0.01
1739
(524, 2922)
36%
(11%, 60%)
0.00
1085
(−5376, 7190)
20.0%
(−97%, 130%)
0.42
tervention time period
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lobes where most of the electromagnetic energy is absorbed (depend-
ing on side of the head where the phone is held when calling) (Cardis
et al., 2008), which has been observed previously (Barchana et al.,
2012; Khurana et al., 2009). As such, it does not speciﬁcally exclude a
speciﬁc association with gliomas (if these occur in the temporal lobe),
which was reported in Interphone (Interphone Study Group, 2010),
and of which about one in three occur in the temporal lobe
(Larjavaara et al., 2007). A stronger causal argument could have been
made if these analyses could have been stratiﬁed by laterality, with ip-
silateral RF exposure having been linked to increased cerebral blood
ﬂow (Huber et al., 2005) and glucose metabolism (Volkow et al.,
2011), as well as to increased risk of glioma in the temporal lobe
(Barchana et al., 2012; Hardell and Carlberg, 2015), although not in all
studies (Hartikka et al., 2009; Larjavaara et al., 2011), but this was not
possible.
The analyses further indicate that the excess incidence in new cases
of malignant neoplasms of the temporal lobe declines again when a 15-
year latency is modelled. There are several possible explanations for
this, which are not mutually exclusive. It may be possible that the posi-
tive ﬁnding for 10-year latency is a chance ﬁnding, although in this case
it is surprising the non-null ﬁnding is observed exactly where hypothe-
sized. Alternatively, this may be the result of reduced exposure as a re-
sult of technological advances that resulted in greatly reduced output
power of the phones and/or the changed use of mobiles that resulted
in less actual calling time (Cardis et al., 2011). It has also been speculat-
ed that such a pattern may be the result of an adaptive response of cells
to RF exposure (Vijayalaxmi and Prihoda, 2014). And ﬁnally, this could
be a methodological artefact resulting from the inclusion of the years
2005–2010, which were previously part of the post-effect period but
now included in the pre-effect period, and therebymay have artiﬁcially
(and erroneously) inﬂated the model coefﬁcients in the pre-effect
period.
An important limitation of this methodology is that the inference
about a (causal) effect relies on the assumption that the relationship be-
tween covariates and the incidence time series prior to the cut-off re-
mains stable through the post-period. Here, the ‘synthetic England’
counterfactual time series was comprehensively estimated based on
set of covariates aimed at capturing temporal changes in population
size, total cancer incidence, the aging population, smoking, urbaniza-
tion, and quality of cancer registration. Although minor changes in any
of these correlations will occur over a 20-year time period, it seems un-
likely that a sudden and substantial difference occurs at the same time
point that the intervention was modelled. In fact, if this were the case
wewould expect similar effects to occur across all selected cancers (un-
less this would be an artefact very speciﬁc to temporal lobe cancers).
Nonetheless, this cannot be excluded either.
As highlighted above, this study does not have the ability to speciﬁ-
cally link incidence tomobile (or cordless) phone use, but infers this as-
sociation by a priori deﬁning a time point when this association would
bemeasurable in population data. As such, this leaves open the possibil-
ity of another causal (environmental) factor; for example ionising radi-
ation exposure (Smoll et al., 2016) and air pollution (Poulsen et al.,
2016) have beenmentioned, but it seems unlikely effects would be lim-
ited to the temporal lobe only. Alternatively, the observed effectmay be
the result of diagnostic bias as a result of the increased volume and qual-
ity of neuroimaging in the last two decades (Zada et al., 2012), although
this would be expected to have occurred in all selected cancers. None-
theless, if in the absence of another probable cause, mobile (and cord-
less) phone use were the causal agent, then this modelling is based on
an inferred exposure metric that includes a wide range of RF frequency
bands since it necessarily includes the use of mobile phones (irrespec-
tive of its generation), cordless phones, and other wireless equipment.
Although not very speciﬁc (as well as inferred instead of measured),
this integration of all RF exposures in one metric can also be regarded
as beneﬁcial. In contrast to the individual-level case-control studies, itis not subject to problems of recall bias and resulting exposuremeasure-
ment error, and potential issues in the selection of study participants
(Ahlbom and others, 2009; Corle et al., 2012; Morgan et al., 2015;
Myung et al., 2009).
The previous analyses of the English brain cancer incidence
trends (de Vocht et al., 2011), but by extension those from other
countries published at the time, were criticized for their short fol-
low-up which, in combination with a lag between exposure and clin-
ical detection of the tumour of at least a decade, would prevent
measureable changes (Kundi, 2011). There remains the possibility
that still not enough time has elapsed for increased risks for gliomas,
GBM4 or malignant neoplasm of the parietal lobe to be detectable.
However, the maximum 15-year latency period since 1995 (or
25 years since 1985 when, roughly, the ﬁrst mobile phones made
their appearance) corresponds to several decades when maximum
impact would be expected (Ahlbom and others, 2009). Therefore, it
seems unlikely that the absence of increased glioma and GBM4 risk
can be attributed to this. Increased risks for asbestos exposure for ex-
ample, with a maximum latency time of 30–40 years could be ob-
served 5–15 years post-exposure (Walker, 1984) and similarly
evidence of atomic bomb survivors indicated that whereas the max-
imum latency of solid tumours is about 50–60 years, excess mortality
risk could be observed after about a decade (Furukawa et al., 2009).
The observed increased incidence of cancers in the temporal lobe
with an implied 10-year latency as such, is consistent with the hy-
pothesis as well as with the latency distributions for solid cancers
observed for asbestos and ionising radiation.
An ﬁnally, because of the aggregated level of these analyses the ob-
served effects, or absence thereof, may be subject to the ecological falla-
cy (Greenland andMorgenstern, 1989), and/or may only be observable
in speciﬁc susceptible subgroups in population such as children (Aydin
et al., 2012), while also these analyses did not include all possible brain
cancer subtypes and locations, including for example vestibular
schwannoma (Morgan et al., 2015).
The statistical methodology here was used to retrospectively
compare the predicted, counterfactual, time series with the mea-
sured annual incidence up to 2014, which enables inference of the
(causal) impact. This, or similar, methodologies are beginning to be
used to ‘nowcast’ trends in health data into the near future
(Donker et al., 2011), and similarly would be useful to continuously
monitor and predict whether an “epidemic” in brain cancers as a re-
sult of the widespread use of mobile phones may be imminent and
what its population impact may be.
In summary, these analyses indicate that a causal factor, of which
mobile phone use (and possibly other wireless equipment) is in agree-
mentwith thehypothesized spatial and temporal associations, is related
to an increased risk of developing amalignant neoplasm in the temporal
lobe.More speciﬁcally, if the calculated population impact is interpreted
as a causal effect and is completely contributed to mobile phone use,
then the population impact is an additional 188 cases annually in En-
gland; corresponding to about 1700 cases (range 436 to 2918) in thepe-
riod 2005–2014 that would not have occurred otherwise. For reference,
this corresponds to 0.02%–0.12%of new cancers during this period. If the
relative effect is interpreted as a population relative risk, then a very
moderate 1.35 (95%CI 1.09:1.59) is observed after a minimum 10-year
latency.Competing ﬁnancial interests
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